Robert W. Hesslein Voyager Therapeutics, Inc. (VYGR) insider trading activity

Robert W. Hesslein is Senior VP & General Counsel of Voyager Therapeutics, Inc.. Currently has a direct ownership of 102,200 shares of VYGR, which is worth approximately $796,138. The most recent transaction as insider was on Mar 20, 2023, when has been sold 4,410 shares (Common Stock) at a price of $7.76 per share, resulting in proceeds of $34,221. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 102K

0% 3M change

0% 12M change

Total Value Held $796,138

Robert W. Hesslein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 20 2023	SELL Open market or private sale	$34,221 $7.76 p/Share	4,410 Reduced 4.14%	102,200 Common Stock
Feb 17 2023	SELL Open market or private sale	$24,562 $7.45 p/Share	3,297 Reduced 3.0%	106,610 Common Stock
Feb 13 2023	SELL Open market or private sale	$21,997 $7.67 p/Share	2,868 Reduced 2.54%	109,907 Common Stock
Jan 17 2023	SELL Open market or private sale	$21,792 $9.96 p/Share	2,188 Reduced 1.9%	112,775 Common Stock
Apr 04 2022	SELL Open market or private sale	$22,984 $8.25 p/Share	2,786 Reduced 2.37%	114,963 Common Stock
Mar 21 2022	SELL Open market or private sale	$42,068 $8.49 p/Share	4,955 Reduced 4.04%	117,749 Common Stock
Feb 17 2022	SELL Open market or private sale	$14,555 $3.55 p/Share	4,100 Reduced 3.23%	122,704 Common Stock

Feb 11 2022	SELL Open market or private sale	$10,927 $3.36 p/Share	3,252 Reduced 2.5%	126,804 Common Stock
Jan 13 2022	BUY Grant, award, or other acquisition	-	20,000 Added 13.33%	130,056 Common Stock
Apr 05 2021	BUY Open market or private sale	$16,295 $4.95 p/Share	3,292 Added 2.9%	110,056 Common Stock
Mar 19 2021	BUY Grant, award, or other acquisition	-	30,000 Added 20.93%	113,348 Common Stock
Feb 16 2021	BUY Grant, award, or other acquisition	-	34,000 Added 28.97%	83,348 Common Stock
Feb 11 2021	SELL Open market or private sale	$24,054 $7.55 p/Share	3,186 Reduced 6.06%	49,348 Common Stock

RWH

Robert W. Hesslein

Senior VP & General Counsel

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYGR shares.

Notify only if

Value

Insider Trading

Get notified when an Voyager Therapeutics, Inc. insider buys or sells VYGR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Voyager Therapeutics, Inc.

Track Activities on VYGR

Account